David R Goodrich

US Patent:

7105156, Sep 12, 2006

Filed:

Jun 7, 1995

Appl. No.:

08/472760

Inventors:

Wen-Hwa Lee - San Antonio TX, US
H. Michael Shepard - Encinitas CA, US
Richard J. Gregory - Westford MA, US
Ken N. Wills - Encinitas CA, US
Daniel C. Maneval - San Diego CA, US
Eva Lee - San Antonio TX, US
David Goodrich - East Aurora NY, US
Nan-Ping Wang - Bellevue WA, US

Assignee:

The Regents of the University of California - Oakland CA
Canji, Inc. - Kenilworth NJ

International Classification:

A61K 35/00
A61K 48/00

US Classification:

424 932, 424 931, 424 9321, 514 44

Abstract:

Disclosed are methods of controlling cell cycle progression by introducing into a cell to be controlled a composition selected from the group consisting of p56protein, a fragment of the p56protein, and the gene encoding p56protein to alter the cell cycle progression while maintaining the viability of the cell. The p56protein has been found to have the unexpected and surprising characteristic of being soluble in low concentrations of glycerol, thereby enhancing its value in pharmaceutical applications and the gene encoding p56when delivered to the hyperproliferating cell inhibits cellular proliferation.

US Patent:

58519912, Dec 22, 1998

Filed:

Sep 13, 1994

Appl. No.:

8/306513

Inventors:

Wen-Hwa Lee - San Antonio TX
Eva Y-H.P. Lee - San Antonio TX
David W. Goodrich - Houston TX
H. Michael Shepard - Rancho Santa Fe CA
Nan Ping Wang - Seattle WA
Duane Johnson - Encinitas CA

Assignee:

The Regents of the University of California - Oakland CA
Canji, Inc. - San Diego CA

International Classification:

A61K 3817

US Classification:

514 12

Abstract:

This invention provides a method of preventing or inhibiting the proliferation of a pathologically proliferating cell, wherein the pathological proliferation of the cell is the result of the absence of a functional retinoblastoma protein or polypeptide in the cell. The method requires contacting the cell with an effective amount of retinoblastoma protein or polypeptide. This method also is useful to prevent or treat retinoblastoma or a secondary cancer to retinoblastoma by administering to a patient a functional retinoblastoma protein or polypeptide.

US Patent:

50169360, May 21, 1991

Filed:

Mar 9, 1990

Appl. No.:

7/491439

Inventors:

David Goodrich - Andover MA

International Classification:

B62D 2500

US Classification:

296 393

Abstract:

The composite liner structure for the interior of motor vehicles in accordance with the present invention includes a sheet section comprising a backing portion of flexible material and an outer surface portion of plush fibers. The plush fibers provide a generally soft resilient face. A pressure sensitive adhesive layer is disposed upon the backing of the sheet section for attaching the backing portion of the liner structure to the interior surface of a motor vehicle. A releasable non-adhesive material cover is disposed on the adhesive layer. The composite liner structure has a predetermined profiled contoured configuration matching the profiled contoured interior surface of the motor vehicle to be lined. Additionally the composite liner structure is preferably formed of thermally insulative material. In one embodiment, the outer surface portion of plush fibers can be provided with decorative indicia.

Address:

26307 Reyglen Dr, San Antonio, TX 78255

Phone:

2106986404

VIN:

5NMSG13D07H112333

Make:

HYUNDAI

Model:

SANTA FE

Year:

2007